Werfen, a leader in Hemostasis diagnostics, is deeply committed to sustainability. We understand the critical role laboratories play in healthcare and strive to minimize our environmental impact. By choosing Werfen, Hemostasis Lab professionals join a community committed to a greener future, supported by sustainable practices. We believe in delivering excellence and at the same time fostering a healthier environment for generations to come.
70 Trees Planted
with every Instrument
Join our growing community of ACL TOP 70 Series Family and contribute to the Grow Together project that consists of planting 70 Trees with each analyzer installed.
This project offsets more than enough CO2 that is generated from the shipping of the analyzer from our manufacturing facilities to your lab.

Environmental
Actions
We are working on several fronts for environmental actions.
We are expanding the number of our facilities that are certified in accordance with ISO 14001 and implementing eco-efficient projects.
We are progressing with the implementation of a cleaner vehicle policy.
And we are also focusing on practical initiatives, such as the complete elimination of single-use plastic bottles and expanding the use of solar panels.
88% of our electrical power is from Clean Energy.

Social
Actions
Annually we support more than 95 different organizations with 200 social and environmental actions which reflects our ongoing commitment to strengthening communities.
Additionally, our solutions continue to make a powerful contribution to the advancement of patient care around the world. We have more than 90,000 active instruments providing clinical results to support medical decisions.

Governance
Actions
We have assigned specific climate-related responsibilities at the management level, a Risk Officer and Vice President of Sustainability; and performed our first Climate change impact study.
We also incorporated 15 new policies related to human rights, labor rights, environment, and anti-corruption.
Werfen received an ESG Risk Rating of 18.8 and was assessed by Morningstar Sustainalytics to be at Low Risk and ranks us in the top 10 of companies rated by Sustainalytics in the Medical Devices sub-industry.
